Advanced Metabolic Research Peptide
Triple receptor agonist for metabolic research applications
Retatrutide
10mg per vial
Lyophilized powder
Metabolic / GLP-1 Research
Store at 2-8°C, protect from light
≥99.9% (HPLC verified)
Retatrutide is a long-acting peptide studied for its triple agonist properties targeting GIP, GLP-1, and glucagon receptors. This novel research compound represents an advanced approach in metabolic pathway investigation.
Research literature explores its potential applications in metabolic regulation and energy expenditure studies, with particular focus on receptor binding mechanisms and downstream signaling pathways.
This compound is intended strictly for in vitro research and laboratory investigation. All studies should be conducted in controlled laboratory environments by qualified research personnel.
This product is sold strictly for research purposes only and is not intended for human consumption, medical, veterinary, or household use.
No therapeutic claims are made. Purchaser must be 18+ and assumes all responsibility for compliance with local regulations.
Vitalyx does not provide medical advice or dosing guidance.